353 related articles for article (PubMed ID: 29117961)
1. Comorbidity increases the risk of relapse in multiple sclerosis: A prospective study.
Kowalec K; McKay KA; Patten SB; Fisk JD; Evans C; Tremlett H; Marrie RA;
Neurology; 2017 Dec; 89(24):2455-2461. PubMed ID: 29117961
[TBL] [Abstract][Full Text] [Related]
2. Relapse prevalence, symptoms, and health care engagement: patient insights from the Multiple Sclerosis in America 2017 survey.
Nazareth TA; Rava AR; Polyakov JL; Banfe EN; Waltrip Ii RW; Zerkowski KB; Herbert LB
Mult Scler Relat Disord; 2018 Nov; 26():219-234. PubMed ID: 30368080
[TBL] [Abstract][Full Text] [Related]
3. Comorbidity in multiple sclerosis: Emphasis on patient-reported outcomes.
Diržiuvienė B; Mickevičienė D
Mult Scler Relat Disord; 2022 Mar; 59():103558. PubMed ID: 35123292
[TBL] [Abstract][Full Text] [Related]
4. Frequency of Comorbidities and Their Association with Clinical Disability and Relapse in Multiple Sclerosis.
Tettey P; Siejka D; Simpson S; Taylor B; Blizzard L; Ponsonby AL; Dwyer T; van der Mei I
Neuroepidemiology; 2016; 46(2):106-13. PubMed ID: 26784322
[TBL] [Abstract][Full Text] [Related]
5. Diabetes and anxiety adversely affect cognition in multiple sclerosis.
Marrie RA; Patel R; Figley CR; Kornelsen J; Bolton JM; Graff L; Mazerolle EL; Marriott JJ; Bernstein CN; Fisk JD;
Mult Scler Relat Disord; 2019 Jan; 27():164-170. PubMed ID: 30384203
[TBL] [Abstract][Full Text] [Related]
6. Comorbidity is associated with disease activity in MS: Findings from the CombiRx trial.
Salter A; Kowalec K; Fitzgerald KC; Cutter G; Marrie RA
Neurology; 2020 Aug; 95(5):e446-e456. PubMed ID: 32554770
[TBL] [Abstract][Full Text] [Related]
7. Investigating the Prevalence of Comorbidity in Multiple Sclerosis Clinical Trial Populations.
Salter A; Lancia S; Kowalec K; Fitzgerald KC; Marrie RA
Neurology; 2024 Mar; 102(5):e209135. PubMed ID: 38350062
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of comorbidities in Multiple Sclerosis and impact on physical disability according to disease phenotypes.
Ciampi E; Uribe-San-Martin R; Soler B; Molnar K; Reyes D; Keller K; Carcamo C
Mult Scler Relat Disord; 2020 Nov; 46():102565. PubMed ID: 33039942
[TBL] [Abstract][Full Text] [Related]
9. Patient-reported outcomes are worse for progressive-onset multiple sclerosis than relapse-onset multiple sclerosis, particularly early in the disease process.
Zhang Y; Taylor BV; Simpson S; Blizzard L; van der Mei I
Eur J Neurol; 2019 Jan; 26(1):155-161. PubMed ID: 30133059
[TBL] [Abstract][Full Text] [Related]
10. Disability progression in multiple sclerosis: a Tunisian prospective cohort study.
Hentati E; Ben Sassi S; Nabli F; Mabrouk T; Zouari M; Hentati F
Neurol Sci; 2018 May; 39(5):879-884. PubMed ID: 29476286
[TBL] [Abstract][Full Text] [Related]
11. Validation of an algorithm to detect severe MS relapses in administrative health databases.
Marriott JJ; Chen H; Fransoo R; Marrie RA
Mult Scler Relat Disord; 2018 Jan; 19():134-139. PubMed ID: 29223870
[TBL] [Abstract][Full Text] [Related]
12. Multiple sclerosis clinical course and cardiovascular disease risk - Swedish cohort study.
Roshanisefat H; Bahmanyar S; Hillert J; Olsson T; Montgomery S
Eur J Neurol; 2014 Nov; 21(11):1353-e88. PubMed ID: 25041631
[TBL] [Abstract][Full Text] [Related]
13. Association of Inflammation and Disability Accrual in Patients With Progressive-Onset Multiple Sclerosis.
Hughes J; Jokubaitis V; Lugaresi A; Hupperts R; Izquierdo G; Prat A; Girard M; Duquette P; Grand'Maison F; Grammond P; Sola P; Ferraro D; Ramo-Tello C; Trojano M; Slee M; Shaygannejad V; Boz C; Lechner-Scott J; Van Pesch V; Pucci E; Solaro C; Verheul F; Terzi M; Granella F; Spitaleri D; Alroughani R; Jun JK; Fambiatos A; Van der Walt A; Butzkueven H; Kalincik T;
JAMA Neurol; 2018 Nov; 75(11):1407-1415. PubMed ID: 30083762
[TBL] [Abstract][Full Text] [Related]
14. Predictors of relapse rate in MS clinical trials.
Held U; Heigenhauser L; Shang C; Kappos L; Polman C;
Neurology; 2005 Dec; 65(11):1769-73. PubMed ID: 16344520
[TBL] [Abstract][Full Text] [Related]
15. Characterizing relapsing remitting multiple sclerosis patients burdened with hypertension, hyperlipidemia, and asthma.
Sorensen A; Conway DS; Briggs FBS
Mult Scler Relat Disord; 2021 Aug; 53():103040. PubMed ID: 34058603
[TBL] [Abstract][Full Text] [Related]
16. Epilepsy in multiple sclerosis: A nationwide population-based register study.
Burman J; Zelano J
Neurology; 2017 Dec; 89(24):2462-2468. PubMed ID: 29117950
[TBL] [Abstract][Full Text] [Related]
17. Defining reliable disability outcomes in multiple sclerosis.
Kalincik T; Cutter G; Spelman T; Jokubaitis V; Havrdova E; Horakova D; Trojano M; Izquierdo G; Girard M; Duquette P; Prat A; Lugaresi A; Grand'Maison F; Grammond P; Hupperts R; Oreja-Guevara C; Boz C; Pucci E; Bergamaschi R; Lechner-Scott J; Alroughani R; Van Pesch V; Iuliano G; Fernandez-Bolaños R; Ramo C; Terzi M; Slee M; Spitaleri D; Verheul F; Cristiano E; Sánchez-Menoyo JL; Fiol M; Gray O; Cabrera-Gomez JA; Barnett M; Butzkueven H
Brain; 2015 Nov; 138(Pt 11):3287-98. PubMed ID: 26359291
[TBL] [Abstract][Full Text] [Related]
18. A cross-sectional study on the relationship between cardiorespiratory fitness, disease severity and walking speed in persons with Multiple Sclerosis.
Madsen LT; Dalgas U; Hvid LG; Bansi J
Mult Scler Relat Disord; 2019 Apr; 29():35-40. PubMed ID: 30658262
[TBL] [Abstract][Full Text] [Related]
19. Fatigue, depression and progression in multiple sclerosis.
Koch M; Uyttenboogaart M; van Harten A; Heerings M; De Keyser J
Mult Scler; 2008 Jul; 14(6):815-22. PubMed ID: 18535019
[TBL] [Abstract][Full Text] [Related]
20. Comorbidity effect on processing speed test and MRI measures in multiple sclerosis patients.
Abbatemarco JR; Ontaneda D; Nakamura K; Husak S; Wang Z; Alshehri E; Bermel RA; Conway DS
Mult Scler Relat Disord; 2020 Nov; 46():102593. PubMed ID: 33296988
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
